Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT01420211Phase 2Completed
A Phase 2 trial of gadoxetate disodium in liver disease, sponsored by Universitätsklinikum Greifswald. Started Oct 2006; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT01420211.